Komori
O

OLBA HEALTHCARE HOLDINGS,Inc.

2689Trading & WholesaleMicro cap
1,909JPY-0.8%
★ Watch (sign-up required)
Price history
¥1,909Latest+27.7%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview

The group described in this report is centered on オルバヘルスケアホールディングス株式会社 and comprises 9 companies across three businesses: the Medical Equipment Business, primarily engaged in the sale of medical equipment; the SPD Business, which handles the sale of medical equipment and procurement management; and the Nursing Care Products Business, which sells and rents beds and other products for home-based care. The business classification is the same as the segment classification. The group has a sales network focused on the Chugoku and Shikoku regions. It carried out a business integration with DVx Inc. effective 1 September 2026 and changed its corporate name to OLBA DVx HEALTHCARE,Inc. Following the integration, it aims to establish a position as a hybrid medical equipment dealer combining comprehensiveness and specialization. The medium-term management plan following the integration is currently being prepared and will be disclosed once finalized.

Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
Loading
Documents
See all timely disclosuresSee all statutory filings
News
See all news
Key numbersShowing 8 of 20
PER
10.68How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.
PBR
0.91How many times the company's net assets? Around 1x is generally considered a benchmark.
ROE
8.5%Earning power. A figure above 10% is generally considered good.
Dividend yield
0.0%The annual dividend as a percentage of the share price.
Market capitalization
¥12bnShare price × number of shares. The value of the entire company.
Equity ratio
28.0%The proportion of assets funded by money that does not have to be repaid.
Operating margin
1.3%The percentage of revenue remaining from the company’s core business.
Revenue growth (3 years)
4.7%The average annual growth in sales over the past three years.
What to watch next
DVxとの経営統合の“統合効果”実現（販売網補完・物流/在庫融通・商品マスタ統合など）
2026年12月期〜2027年6月期にかけての決算で進捗確認Impact HighLikelihood Medium
PBR1倍割れ脱却に向けた収益改善（営業利益率の底打ち〜改善）
次の通期決算（時期は未確定）Impact MediumLikelihood Medium
自社/連結子会社での新規プロダクト拡大（例：RAQUOSインジェクション、テマサック等の進捗）
2026年12月期〜2027年に実績開示が増えるタイミングImpact MediumLikelihood Low
資本効率・財務健全性（長期借入金の減少が継続し、FCFが改善するか）
Quarterly, with ongoing monitoringImpact MediumLikelihood Medium
What to watch next
Loading
Who owns itTop holders total 51.5%
Listed holders 51.5%Everyone else 48.5%
株式会社マスプ13.91%
Maejima Tatsuya (前島 達也)7.42%
オルバヘルスケア Employees' Stock Ownership Plan6.18%
The San-in Godo Bank,Ltd.4.51%
The Chugoku Bank, Ltd.4.49%
株式会社日本カストディ銀行 (Trust Account)4.07%
光通信ＫＫ投資事業有限責任組合3.41%
The Iyo Bank, Ltd.2.67%
2 other listed holders4.86%
Who owns it
HolderOwnership (%)
株式会社マスプ13.91
Maejima Tatsuya (前島 達也)7.42
オルバヘルスケア Employees' Stock Ownership Plan6.18
The San-in Godo Bank,Ltd.4.51
The Chugoku Bank, Ltd.4.49
株式会社日本カストディ銀行 (Trust Account)4.07
光通信ＫＫ投資事業有限責任組合3.41
The Iyo Bank, Ltd.2.67
2 other listed holders4.86
This company's documents
Filings
Timely disclosures
Threads